1. Home
  2. FRAF vs AVIR Comparison

FRAF vs AVIR Comparison

Compare FRAF & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Financial Services Corporation

FRAF

Franklin Financial Services Corporation

N/A

Current Price

$67.94

Market Cap

310.9M

Sector

Finance

ML Signal

N/A

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

N/A

Current Price

$3.89

Market Cap

334.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FRAF
AVIR
Founded
1906
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
310.9M
334.5M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
FRAF
AVIR
Price
$67.94
$3.89
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $9.00
AVG Volume (30 Days)
43.4K
★ 275.6K
Earning Date
10-27-2026
11-09-2026
Dividend Yield
★ 2.00%
N/A
EPS Growth
★ 88.84
3.00
EPS
★ 4.84
N/A
Revenue
N/A
★ $351,367,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.58
N/A
P/E Ratio
$14.08
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$45.16
$2.93
52 Week High
$73.69
$6.45

Technical Indicators

Market Signals
Indicator
FRAF
AVIR
Relative Strength Index (RSI) 51.19 34.92
Support Level $60.62 N/A
Resistance Level $73.69 $4.63
Average True Range (ATR) 1.95 0.25
MACD -0.40 0.00
Stochastic Oscillator 6.27 6.20

Price Performance

Historical Comparison
FRAF
AVIR

About FRAF Franklin Financial Services Corporation

Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking, and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals, and governmental entities, which include accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Share on Social Networks: